Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Castle Biosciences Incorporated

Clinical trials sponsored by Castle Biosciences Incorporated, explained in plain language.

Castle Biosciences Incorporated CSTL NASDAQ

Diagnostics company for skin cancers.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

Eczema flare predictor device tested in new study

Knowledge-focused Recruiting now

This study is testing a handheld device called Nevisense Go to see if it can predict eczema (atopic dermatitis) flares before they become visible or cause symptoms. About 450 people aged 12 to 89 with a history of eczema flares will use the device at home for 90 days. The goal is…

Sponsor: Castle Biosciences Incorporated • Aim: Knowledge-focused

Last updated Jun 27, 2026 13:06 UTC